Form 4: Bluebird Bio Executive Thomas Klima Sells Shares to Cover Tax Obligations
SEC Form 4
Thomas Klima, Chief Commercial & Operating Officer of bluebird bio, sold 500 shares of common stock on March 3, 2025, to cover tax withholding obligations.
Summary
- Thomas J. Klima, Chief Commercial & Operating Officer of bluebird bio, Inc., executed a sale of company stock on March 3, 2025.
- The transaction involved the disposal of 500 shares of common stock at an average price of $3.9194 per share.
- The sale was conducted to cover tax withholding obligations related to the vesting of Restricted Stock Units.
- Following the transaction, Klima directly owns 7,878 shares of bluebird bio, Inc.
- The reporting was filed by Sydney Gaylin, Attorney-in-Fact, on March 5, 2025.
Sentiment
Score: 6
Explanation: The document is a standard regulatory filing related to an insider stock sale. The sale is for tax obligations, which is a neutral event. Therefore, the sentiment is neutral.
Industry Context
This is a routine Form 4 filing, indicating an insider transaction. Such filings are common and provide transparency into the trading activities of company executives. The sale appears to be related to tax obligations, which is a typical reason for such transactions.
Stakeholder Impact
- The transaction has a minimal impact on stakeholders as it is a small sale by an executive to cover tax obligations.
Key Dates
| Date | Description |
|---|---|
| 2024-09-24 | Date of Power of Attorney execution. |
| 2025-03-03 | Date of stock sale transaction. |
| 2025-03-05 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.